Delivery Order SPE2DX22D0010-SPE2D826FBL64
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $35,100.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,337.35 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,795.28 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price, non-set-aside delivery order was competitively awarded and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $24,314.34 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $28,813.47 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with a completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The work...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $11,176.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract is a child award under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $10,051.44 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies to support federal medical procurement needs. The contract was performed at the awardee's Corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $15,683.84 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $57,286.44 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, non-set-aside delivery order was issued under the company's existing indefinite delivery contract (IDC) and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20,927.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBL64Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $10,261.60 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's delivery orders through the DLA Medical Supply Chain vehicle typically encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This competitively awarded contract reflects AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements and serve key customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 12/2/25 |